VIPAX Mutual Fund

NAV$29.76

Fund Essentials - as of Apr 30, 2026

Net Assets
$1M
Expense Ratio
1.05%
Dividend Yield (Current)
11.84%
Holdings
227
Inception Date
Aug 24, 2018
Fund Family
Voya Investment Management
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD-1.36%
1 Year+20.38%
3 Year+19.01%
5 Year+11.87%

Asset Allocation

Stocks: 98.03%
Other: 1.97%

Price Chart (6M)

View Full Chart →

Top Holdings

View All →
TickerNameWeight
NVDANvidia Corp.8.15%
GOOGLAlphabet Inc Common Stock USD 0.0016.06%
AAPLApple, Inc5.83%
MSFTMicrosoft Corp 4.100 Feb 06 374.75%
AMZNAmazon.Com Inc4.60%
Top 10 Concentration: 38.19%Report Date: Apr 30, 2026
Download all 227 holdings for VIPAX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
11.84%
Frequency
Annually
Latest Distribution
$2.35
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how VIPAX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

VIPAX Mutual Fund Overview

VIPAX Mutual Fund (Voya Index Plus LargeCap Portfolio Advisor Class) is managed by Voya Investment Management with $1.4M in net assets. VIPAX expense ratio is 1.05%, holding 227 positions across sectors including Information Technology, Unknown, Communication Services. Inception date: 2018-08-24.

VIPAX performance shows a YTD return of -1.36%. The 1-year return is 20.38% and the 5-year return is 11.87%. VIPAX dividend yield stands at 11.84%, paid annually.

VIPAX top holdings include Nvidia Corp. (8.2%), Alphabet Inc Common Stock USD 0.001 (6.1%), Apple, Inc (5.8%), Microsoft Corp 4.100 Feb 06 37 (4.8%), Amazon.Com Inc (4.6%). View all VIPAX holdings, sector breakdown, or dividend history.

VIPAX can be compared against other funds using the overlap calculator or side-by-side comparison tool. VIPAX alternatives are available via the screener, along with tax-loss harvesting opportunities.